<span id="m_7423859636789438450m_-6683468722331399084gmail-docs-internal-guid-f10b8264-7fff-3c7e-5061-ebf779f07971" style="color: #222222;"><span style="background-color: transparent; color: #000000;">The indigenously developed Bangavax covid vaccine has received the ethical permission from the Bangladesh Medical Research Council (BMRC) to start the human trial. <br />''<br />''The vaccine developed by the local Bangladeshi pharmaceutical company Globe Biotech Limited completed the trial on animals as required by the BMRC to grant permission for human trials. The company will now submit an application to the Directorate General of Drug Administration (DGDA) seeking its permission for the clinical trials.<br />''<br />''Globe Biotech Limited has claimed that Bangavax is 100 percent effective against 11 variants of COVID 19 including the Delta variant, reports UNB.<br />''<br />''Globe Biotech is the only Bangladeshi company working on the development of the COVID 19 vaccine. </span><br />''</span><span style="background-color: transparent; color: #000000;">The human trial will be conducted in four phases through a third party clinical research organization.</span><br />